Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://www.nature.com/articles/6702964.pdf
Reference66 articles.
1. Day DG, Schacknow PN, Sharpe ED, Ellyn JC, Kulze JC, Threlkeld AB et al. A persistency and economic analysis of latanoprost, bimatoprost or beta-blockers in patients with open-angle glaucoma or ocular hypertension. J Ocul Pharmacol Ther 2004; 20: 383–392.
2. Reardon G, Schwartz GF, Mozaffari E . Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol 2004; 137: S3–S12.
3. Schwartz GF, Reardon G, Mozaffari E . Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Ophthalmol 2004; 137: S13–S16.
4. Sherwood M, Brandt J, Bimatoprost Study Groups 1 and 2. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol 2001; 45: S361–S368.
5. Netland PA, Landry T, Sullivan K, Andrew R, Silver L, Weiner A et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001; 132: 472–484.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Manufacturing and characterisation of 3D-printed sustained-release Timolol implants for glaucoma treatment;Drug Delivery and Translational Research;2024-04-05
2. Systematic methodological review of health state values in glaucoma cost-utility analyses;The European Journal of Health Economics;2024-02-27
3. AN EVALUATION OF EFFICACY OF COMMONLY USED FIRST LINE DRUGS IN TERMS OF INTRA OCULAR PRESSURE, OCULAR PERFUSION PRESSURE, AND FIELD OF VISION IN PATIENTS OF PRIMARY OPEN ANGLE GLAUCOMA OF NORTH KARNATAKA;Asian Journal of Pharmaceutical and Clinical Research;2023-03-07
4. Effect of prostaglandins and beta blockers on progression of hypertensive and normotensive glaucomas;Biomedical Papers;2021-06-10
5. Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma Care;Current Eye Research;2021-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3